Zobrazeno 1 - 10
of 5 793
pro vyhledávání: ''
Autor:
Michael C. Kolios, Kashuf Fatima, Daniel DiCenzo, Greg J. Stanisz, Nicole J. Look Hong, Lakshmanan Sannachi, Divya Bhardwaj, Andrea Eisen, William T. Tran, Karina Quiaoit, Robert Dinniwell, Belinda Curpen, Frances C. Wright, Sonal Gandhi, Maureen E. Trudeau, Christine B. Brezden, Mehrdad J. Gangeh, Archya Dasgupta, Wei Yang, Gregory J. Czarnota, Arjun Sahgal, Ali Sadeghi-Naini
Publikováno v:
Cancer Medicine, Vol 9, Iss 16, Pp 5798-5806 (2020)
Cancer Medicine
Cancer Medicine
Background This study was conducted in order to develop a model for predicting response to neoadjuvant chemotherapy (NAC) in patients with locally advanced breast cancer (LABC) using pretreatment quantitative ultrasound (QUS) radiomics. Methods This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2018776d702f0a355eb56e7355a5e007
https://doi.org/10.32920/21290982
https://doi.org/10.32920/21290982
Autor:
Zekuan Xu, Yiwen Xia, Zhe Xuan, Li Xie, Tianlu Jiang, Sen Wang, Zhongyuan He, Shengkui Qiu, Linjun Wang, Jialun Lv, Ying Li, Bowen Li
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-18 (2021)
Molecular Cancer
Molecular Cancer
Background A novel type of noncoding RNA, circRNA has been reported to participate in the occurrence and development of diseases through many mechanisms. The MAPK pathway is a common signal transduction pathway involved in cell proliferation, inflamm
Autor:
Yan-Xing Chen, Huai-Qiang Ju, Zhan-Hong Chen, Jia-jia Hu, Rui-Hua Xu, Ying-Nan Wang, Jia-huan Lu, Hui Sheng, Yun Wang, Kai Yu, Pei-Shan Hu, Zexian Liu, Jia-Bo Zheng, Hai-Yu Mo, Qi-Nian Wu, Dong-dong Yang, Zhao-Lei Zeng
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2423-2441 (2021)
Cancer Medicine
Cancer Medicine
Background Numerous reports on microRNAs have illustrated their role in tumor growth and metastasis. Recently, a new prognostic factor, miR‐125b‐2‐3p, has been identified for predicting chemotherapeutic sensitivity in advanced colorectal cancer
Autor:
F. Stephen Hodi, Lisa Magarace, Jason L. Weirather, Brian J. Quattrochi, Nancy Bailey, Rizwan Haq, Michael Manos, Lynette M. Sholl, Patrick A. Ott, Elizabeth I. Buchbinder, Ryan C. Brennick, Anita Giobbie-Hurder, Peter Bowling, Benjamin Izar
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2627-2635 (2021)
Cancer Medicine
Cancer Medicine
Mucosal melanoma is a rare form of melanoma which arises from melanocytes in the mucosal membranes and can be effectively treated with immune checkpoint blockade (ICB). However, response rates in mucosal melanoma are lower than those observed for cut
Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
Autor:
Yuan Cheng, Xuejiao Han, Qingfang Li, Fei Mo, Xiawei Wei, Yuquan Wei, Houhui Shi, Siyuan Chen
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-21 (2021)
Molecular Cancer
Molecular Cancer
Background Drug-resistance and severe side effects of chemotherapeutic agents result in unsatisfied survival of patients with lung cancer. CXCLs/CXCR2 axis plays an important role in progression of cancer including lung cancer. However, the specific
Autor:
Jendrik Hardes, Arne Streitbürger, Stéphane Collaud, Theresa Stork, Rebecca Boemans, Christoph Pöttgen, Hans-Ulrich Schildhaus, Uta Dirksen, Clemens Aigner, Sebastian Bauer
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Cancer
BMC Cancer
Background Pulmonary metastasectomy (PM) is an established treatment for selected patients with metastatic sarcomas. The aim of this study was to examine our institutional experience and evaluate factors predicting outcome. Methods We retrospectively
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2489-2495 (2021)
Cancer Medicine
Cancer Medicine
Background Increasing evidence, including multiple putative inflammatory risk factors (e.g., c‐reactive protein, and adiposity), supports that inflammation plays an important role in ovarian carcinogenesis. Resistance training (RT) is associated wi
Autor:
Nicolas Boissel, Nicola Gökbuget, Anthony S. Stein, Max S. Topp, Hagop M. Kantarjian, Yuqi Chen, Gerhard Zugmaier, Heinz-August Horst, Monika Brüggemann, Giovanni Martinelli
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2601-2610 (2021)
Cancer Medicine
Cancer Medicine
Background Blinatumomab is a BiTE® immuno‐oncology therapy indicated for the treatment of patients with relapsed or refractory (r/r) B‐cell precursor (BCP) acute lymphoblastic leukemia (ALL). Aims To assess the efficacy and safety of blinatumoma
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2904-2913 (2021)
Cancer Medicine
Cancer Medicine
This study aimed to explore the epidemiological characteristics of breast cancer and establish an Exponential Smoothing (ETS) and Autoregressive Integrated Moving Average (ARIMA) models to predict the development of incidence in Shantou. This study h
Autor:
Minoru Fukuda, Hiroshi Gyotoku, Noritaka Honda, Yasuhiro Umeyama, Yosuke Dotsu, Takumi Nakao, Hiroshi Mukae, Mutsumi Ozasa, Kojima Tomohito, Junya Fukuoka, Hirokazu Taniguchi, Takayuki Suyama, Noriho Sakamoto, Taiga Miyazaki, Yasushi Obase, Shinnosuke Takemoto, Hiroyuki Yamaguchi
Publikováno v:
Thoracic Cancer, Vol 12, Iss 7, Pp 1126-1130 (2021)
Thoracic Cancer
Thoracic Cancer
Pulmonary sarcomatoid carcinoma (SC) is an aggressive subtype of lung cancer that exhibits resistance to cytotoxic chemotherapy. Although programmed cell death 1 (PD‐1) inhibitors have been reported to show antitumor effects in patients with high p